Contact this trialFirst, we need to learn more about you.
Radiopharmaceutical
Flexible Dosing of 177Lu-PSMA-617 for Advanced Prostate Cancer
Recruiting1 awardPhase 2
Los Angeles, California
This trial is testing a new treatment schedule for patients with advanced prostate cancer that has spread to other parts of the body. The current standard treatment involves 6 cycles of a therapy called 177Lu-pro
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service